AstraZeneca PLC
Investors that purchased the Company’s securities and have suffered a loss, please fill in transaction information below, or email to info@portnoylaw.com.
There is no cost or obligation associated with submitting your information. If you are a shareholder who suffered a loss, please submit your contact information and purchase information to participate in the putative class action.
We also encourage you to contact Lesley F. Portnoy of The Portnoy Law Firm, at 310.692.8883, to discuss your rights free of charge. You can also reach us through the firm’s website at www.portnoylaw.com, or by email at info@portnoylaw.com.
If you choose to take no action, you can remain an absent class member.
Joining the case through the Portnoy Law website enables investors to learn about their legal claims and take an active role in recovering their losses.
The Portnoy Law Firm represents investors around the world and specializes in securities class action lawsuits and shareholder rights litigation.
CONTACT:
Portnoy Law Firm
Lesley F. Portnoy, Esq.,
www.portnoylaw.com
Office: 310.692.8883
1800 Century Park East, Suite 600
Los Angeles, CA 90067
info@portnoylaw.com
The lawsuit claims that during the Class Period, the defendants made false and/or misleading statements and/or failed to disclose the following: (1) AstraZeneca was involved in insurance fraud in China; (2) this led to increased legal risks in China, culminating in the detention of the AstraZeneca China President by Chinese authorities; (3) AstraZeneca downplayed its legal risks; (4) once revealed, the situation could severely impact AstraZeneca’s operations in China; and (5) as a result, the defendants’ statements about the company’s business, operations, and future prospects were either false, misleading, or lacked a reasonable foundation at all relevant times. The lawsuit asserts that when the truth became known, investors suffered financial losses.
